«Radiotherapy

Below is an extended Radiotherapy patents listing. Click here to return to the Radiotherapy main in depth entry.

Patents :
US Patent No.	Title
7423065	Therapeutic use of methionine-derivitives to reduce the toxicity of noise
7425607	Compositions comprising a lung tumor antigen
7425610	Methods and materials relating to CD84-like polypeptides and polynucleotides
7425617	Antibodies to the cell cycle regulatory protein p16
7425618	Stabilized anti-respiratory syncytial virus (RSV) antibody formulations
7425619	Fc.gamma.RIIB specific antibodies and methods of use thereof
7425620	Fc.gamma.RIIB-specific antibodies and methods of use thereof
7425635	Prodrugs and conjugates of thiol- and selenol-containing compounds and methods of use thereof
7425717	Particle beam irradiation apparatus, treatment planning unit, and particle beam irradiation method
7426256	Motion-corrected three-dimensional volume imaging method
7426318	Motion field generation for non-rigid image registration
7425565	Use of benzothiopenes to treat and prevent prostate cancer
7425553	Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
7425549	Drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis
7423157	Substituted benzimidazoles and their use for inducing apoptosis
7423278	Ion acceleration system for hadrontherapy
7423429	Apparatus and associated method that integrate the modalities of diagnosis and therapy to treat, in principle, pathologies generically identified as Cancer and HIV/AIDS
7425218	Nitric oxide-releasing medical devices
7425317	Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
7425330	Methods of inhibiting TNF.alpha. activity in the blood of a patient
7425421	Method for the enumeration of micronucleated erythrocyte populations while distinguishing platelets and/or platelet-associated aggregates
7425538	HAUSP-p53 interaction and uses thereof
7425544	Modulation of eIF4E expression
7425545	Modulation of C-reactive protein expression
7426409	Method and apparatus for detecting vulnerable atherosclerotic plaque
7426929	Intra/extra-thoracic collateral ventilation bypass system and method
7429383	Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
7429458	Methods of using bioelastomers
7429481	Targeting viruses using a modified sindbis glycoprotein
7429489	Methods of controlling proliferation and differentiation of stem and progenitor cells
7429578	Tricyclic inhibitors of poly(ADP-ribose) polymerases
7429639	SSX-2 peptides presented by HLA class II molecules
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7429650	Methods and compositions in breast cancer diagnosis and therapeutics
7429660	ATM inhibitors
7429681	Combretastatin analogs with tubulin binding activity
7429382	Antibodies that bind cell-associated CA 125/O772P and methods of use thereof
7427657	Aromatic sulfenates for type 1 phototherapy
7427626	2-Anilino-4-(imidazol-5-yl)-pyrimidine derivatives and their use as cdk (cdk2) inhibitors
7427390	Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
7427393	Pharmaceutical preparation containing magnetic vesicular particles, manufacturing method thereof and diagnostic therapeutic system
7427395	Chemotherapeutic agent-incorporated pharmaceutical preparation
7427399	Antibodies and related molecules that bind to 161P2F10B proteins
7427470	Antisense modulation of helicase-moi expression
7427492	Polynucleotides encoding human tumor necrosis factor receptor-like2
7427600	Active agent delivery systems and methods for protecting and administering active agents
7427603	Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
7427616	Condensed pyridines and pyrimidines with tie2 (TEK) activity
7427623	4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof
7430449	Methods and apparatus for testing disruption of a vagal nerve

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.